Carr Financial Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Buy
1,428
+2
+0.1% +$553 0.07% 150
2026
Q1
$421K Buy
1,426
+35
+3% +$10.4K 0.11% 109
2025
Q4
$380K Buy
1,391
+8
+0.6% +$2.17K 0.1% 126
2025
Q3
$374K Buy
1,383
+6
+0.4% +$1.63K 0.1% 125
2025
Q2
$379K Buy
1,377
+6
+0.4% +$1.63K 0.11% 120
2025
Q1
$364K Sell
1,371
-416
-23% -$103K 0.12% 118
2024
Q4
$415K Buy
1,787
+9
+0.5% +$2.07K 0.13% 115
2024
Q3
$392K Buy
1,778
+9
+0.5% +$1.86K 0.12% 127
2024
Q2
$348K Buy
1,769
+10
+0.6% +$2.07K 0.11% 134
2024
Q1
$379K Sell
1,759
-15
-0.8% -$3.15K 0.13% 126
2023
Q4
$374K Hold
1,774
0.14% 113
2023
Q3
$370K Hold
1,774
0.15% 106
2023
Q2
$329K Hold
1,774
0.13% 123
2023
Q1
$340K Hold
1,774
0.15% 116
2022
Q4
$306K Buy
+1,774
New +$308K 0.16% 122

Other funds holding CME

Carr Financial Group's CME Position: Q2 2026 in Review

Carr Financial Group increased its CME Group (CME) stake by 0.14% in Q2 2026, buying an estimated $553 and bringing the position to 1,428 shares worth $315K. The position accounts for 0.07% of the portfolio, ranked #150.

Carr Financial Group first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $421K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Carr Financial Group held 1,428 shares of CME Group worth $315K as of Q2 2026.
  • Carr Financial Group bought 2 CME Group shares in Q2 2026, an estimated $553.
  • CME Group made up 0.07% of Carr Financial Group's portfolio in Q2 2026, its #150 holding.
  • Carr Financial Group first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Carr Financial Group's CME Group position peaked at $421K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.